Open an account

Shanghai Fosun Pharmaceutical Group

SFOSF · SHANGHAI

$2.18+$2.18 (+0.00%)TodayMarket closed ·
No price history for this range.

About SFOSF

Shanghai Fosun Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. Shanghai Fosun Pharmaceutical (Group) Co Ltd is a China-based company principally engaged in the research, development, manufacturing and sales of pharmaceutical products. The firm operates its businesses through five segments. The Pharmaceuticals segment is primarily engaged in the research, development, production and sales of pharmaceuticals. The Medical Devices and Diagnostics segment is primarily engaged in the research, development, production and sales of medical devices and diagnostic products. The Healthcare Services segment is primarily engaged in the provision of healthcare services and hospital management. The Pharmaceutical Distribution and Retail segment primarily engages in the distribution and retail of pharmaceuticals and medical devices. The firm also operates the Other segment. The firm mainly operates its businesses in the domestic market and overseas markets.

Employees
40,603
Headquarters
Shanghai, Shanghai
Listed
Aug 7, 1998
Sector
Health Care
Industry
Pharmaceuticals
Website
fosunpharma.com

SFOSF key statistics

Market cap
56.61B
Price-earnings ratio
0.00
Dividend yield
3.24%
Average volume
100
Volume
100
Open price
$2.18
High today
$2.18
Low today
$2.18
52 Week high
$2.86
52 Week low
$1.93

Shanghai Fosun Pharmaceutical Group (SFOSF) at a glance

Shanghai Fosun Pharmaceutical Group (SFOSF) last traded at $2.18, with a market cap of 56.61B, a price-to-earnings ratio of 0.00 and a dividend yield of 3.24%.

Volume so far is 100 shares, in line with the average of 100 shares a day.

Over the past year Shanghai Fosun Pharmaceutical Group has ranged from $1.93 to $2.86, and now sits 26% of the way up that range.

Shanghai Fosun Pharmaceutical Group met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.32 per share against an estimate of $0.3586.

SFOSF earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 10.1% on average.

  1. Q3 FY24: reported $0.29 per share against an estimate of $0.298
  2. Q4 FY24: reported $0.29 per share against an estimate of $0.2576
  3. Q1 FY25: reported $0.29 per share against an estimate of $0.298
  4. Q2 FY25: reported $0.35 per share against an estimate of $0.2778
  5. Q3 FY25: reported $0.31 per share against an estimate of $0.303
  6. Q4 FY25: reported $0.32 per share against an estimate of $0.2929
  7. Q1 FY26: reported $0.33 per share against an estimate of $0.3283
  8. Q2 FY26: reported $0.32 per share against an estimate of $0.3586

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.